Company / Depreciation & Amortization
TELA Bio, Inc. Depreciation & Amortization History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$428.0K
FY2025
5-year range
$221.0K / $428.0K
FY2021-FY2025
Trend
+11.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has increased for 3 consecutive years, from $221,000 in FY2022 to $428,000 in FY2025.
Based on SEC 10-K filings.
$428,000 in FY2025 with a 5-year CAGR of -1.6%.
Increased from $231,000 to $428,000 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +24.6%
- 5-Year CAGR
- -1.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- TELA Bio, Inc.'s depreciation & amortization has grown for 3 consecutive years.
- 5-year CAGR of -1.6%, indicating a declining trend.
- In FY2025, depreciation & amortization increased 11.7% year-over-year.
- Peak depreciation & amortization was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $428.0K | +11.7% |
| FY2024 | $383.0K | +65.8% |
| FY2023 | $231.0K | +4.5% |
| FY2022 | $221.0K | -20.5% |
| FY2021 | $278.0K | -40.0% |
| FY2020 | $463.0K | -39.2% |
| FY2019 | $761.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026